Blood Serum and Erythrocyte Lipidomic Profiling Revealed Diagnostic Biomarkers in Patients with Early Stages of CRC and Adenomatous Polyps Conference Abstracts
Conference |
28th United European Gastroenterology Week Virtual 2020 11-13 Oct 2020 , Online |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Journal |
United European Gastroenterology Journal
ISSN: 2050-6406 , E-ISSN: 2050-6414 |
||||||||||
Output data | Year: 2020, Volume: 8, Number: 8_suppl, Pages: 527 Pages count : 1 DOI: 10.1177/2050640620927345 | ||||||||||
Tags | COLORECTAL CANCER, FATTY ACIDS, EARLY STAGES | ||||||||||
Authors |
|
||||||||||
Affiliations |
|
Abstract:
Objective: A) To investigate if discriminant lipidomics could be used as a potential diagnostic tool for early stages of colorectal cancer (esCRC) and precancerous condition adenomatous polyps (AP). B) to create a list of fatty acids (FAs) in the erythrocyte membranes (Er) and in blood serum (BS), the levels of which can be used as biomarkers of esCRC and AP. C) To investigate the accuracy of machine learning methods and different FAs sets to classify esCRC and AP patients from healthy individuals.
Aims & Methods: A total of 65 CRC patients with disease stages 1 and 2, as well as 25 patients with adenomatous polyps, and 35 conditionally healthy persons were included. The analysis of the Er and BS fatty acids (FAs) composition has been carried out using a gas chromatography-mass spectrometry (GC/MS) system based on the Agilent 7000B Triple Quadrupole (USA). Measured sets of FAs and two machine learning methods (support vector machine and random forest) were used to classify esCRC and AP patients from healthy participants as well as esCRC patients from AP.
Results: We have determined the levels of >30 FAs and their ratios in BS and Er membranes for the proband groups...
Cite:
Kruchinina M.V.
, Gromov A.A.
, Kruchinin V.N.
, Shashkov M.V.
, Sokolova A.S.
, Shestov A.A.
Blood Serum and Erythrocyte Lipidomic Profiling Revealed Diagnostic Biomarkers in Patients with Early Stages of CRC and Adenomatous Polyps
United European Gastroenterology Journal. 2020.
V.8. N8_suppl. P.527. DOI: 10.1177/2050640620927345
Scopus
РИНЦ
OpenAlex
Blood Serum and Erythrocyte Lipidomic Profiling Revealed Diagnostic Biomarkers in Patients with Early Stages of CRC and Adenomatous Polyps

Files:
Full text from publisher
Dates:
Published print: | Oct 1, 2020 |
Published online: | Oct 10, 2020 |
Identifiers:
Scopus: | 2-s2.0-85092753863 |
Elibrary: | 44090671 |
OpenAlex: | W3212599147 |